Athersys, Inc. (ATHX): Price and Financial Metrics


Athersys, Inc. (ATHX): $1.63

0.46 (+39.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATHX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ATHX POWR Grades

  • Value is the dimension where ATHX ranks best; there it ranks ahead of 55.51% of US stocks.
  • The strongest trend for ATHX is in Quality, which has been heading down over the past 179 days.
  • ATHX ranks lowest in Stability; there it ranks in the 1st percentile.

ATHX Stock Summary

  • As for revenue growth, note that ATHX's revenue has grown 692.18% over the past 12 months; that beats the revenue growth of 98.71% of US companies in our set.
  • The volatility of ATHERSYS INC's share price is greater than that of 99.76% US stocks with at least 200 days of trading history.
  • ATHERSYS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -162.99%, greater than the shareholder yield of only 2.95% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ATHERSYS INC, a group of peers worth examining would be SYRS, ABUS, PIRS, ALT, and CNCE.
  • ATHX's SEC filings can be seen here. And to visit ATHERSYS INC's official web site, go to www.athersys.com.

ATHX Valuation Summary

  • In comparison to the median Healthcare stock, ATHX's EV/EBIT ratio is 102.5% lower, now standing at -0.2.
  • Over the past 186 months, ATHX's EV/EBIT ratio has gone down 0.1.

Below are key valuation metrics over time for ATHX.

Stock Date P/S P/B P/E EV/EBIT
ATHX 2022-09-23 1.7 -1.5 -0.2 -0.2
ATHX 2022-09-22 1.2 -1.1 -0.2 -0.1
ATHX 2022-09-21 1.4 -1.2 -0.2 -0.1
ATHX 2022-09-20 1.6 -1.5 -0.2 -0.2
ATHX 2022-09-19 1.6 -1.5 -0.2 -0.2
ATHX 2022-09-16 2.0 -1.8 -0.3 -0.2

ATHX Growth Metrics

    Its 2 year cash and equivalents growth rate is now at -33.33%.
  • Its 5 year price growth rate is now at 58.43%.
  • Its 2 year price growth rate is now at -76.23%.
Over the past 52 months, ATHX's revenue has gone up $7,438,000.

The table below shows ATHX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 10.742 -75.597 -83.752
2022-03-31 8.426 -79.26 -82.703
2021-12-31 5.514 -76.185 -86.955
2021-09-30 6.062 -74.126 -87.45
2021-06-30 1.356 -74.157 -93.816
2021-03-31 1.44 -66.8 -89.589

ATHX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATHX has a Quality Grade of C, ranking ahead of 38.11% of graded US stocks.
  • ATHX's asset turnover comes in at 0.02 -- ranking 368th of 682 Pharmaceutical Products stocks.
  • INFI, NLTX, and LCTX are the stocks whose asset turnover ratios are most correlated with ATHX.

The table below shows ATHX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.020 1 7.687
2021-03-31 0.020 1 6.179
2020-12-31 0.023 1 6.796
2020-09-30 0.008 1 7.038
2020-06-30 0.000 1 6.688
2020-03-31 0.092 1 6.754

ATHX Price Target

For more insight on analysts targets of ATHX, see our ATHX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.75 Average Broker Recommendation 1.38 (Strong Buy)

ATHX Stock Price Chart Interactive Chart >

Price chart for ATHX

ATHX Price/Volume Stats

Current price $1.63 52-week high $36.00
Prev. close $1.17 52-week low $1.13
Day low $1.16 Volume 40,327,700
Day high $2.10 Avg. volume 582,983
50-day MA $4.35 Dividend yield N/A
200-day MA $13.35 Market Cap 17.94M

Athersys, Inc. (ATHX) Company Bio


Athersys, Inc. focuses on the research and development activities in the field of regenerative medicine. The company was founded in 1995 and is based in Cleveland, Ohio.


ATHX Latest News Stream


Event/Time News Detail
Loading, please wait...

ATHX Latest Social Stream


Loading social stream, please wait...

View Full ATHX Social Stream

Latest ATHX News From Around the Web

Below are the latest news stories about ATHERSYS INC that investors may wish to consider to help them evaluate ATHX as an investment opportunity.

The Three Best Anti-Aging Stocks to Buy in September

Innovative medical technology companies and anti-aging stocks are the subject of much interest on Wall Street

Tezcan Gecgil on InvestorPlace | September 19, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're breaking down the biggest pre-market stock movers and the news that has them rising and falling for Monday morning!

William White on InvestorPlace | August 29, 2022

Athersys shares lose 4.6% on first trading day after reverse stock split

Athersys shareholders approved a reverse stock split primarily to bring Athersys into compliance with Nasdaq’s minimum bid price requirement of $1.

Yahoo | August 29, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

William White on InvestorPlace | August 26, 2022

Athersys plans reverse stock split by Monday's market opening

In July, shareholders approved a reverse stock split to bring Athersys into compliance with Nasdaq’s minimum bid price requirement.

Yahoo | August 25, 2022

Read More 'ATHX' Stories Here

ATHX Price Returns

1-mo -49.85%
3-mo -75.40%
6-mo -89.67%
1-year -95.38%
3-year -95.06%
5-year -97.34%
YTD -92.78%
2021 -48.42%
2020 42.28%
2019 -14.58%
2018 -20.44%
2017 18.30%

Continue Researching ATHX

Here are a few links from around the web to help you further your research on Athersys Inc's stock as an investment opportunity:

Athersys Inc (ATHX) Stock Price | Nasdaq
Athersys Inc (ATHX) Stock Quote, History and News - Yahoo Finance
Athersys Inc (ATHX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6383 seconds.